Showing results (41-50 of 587) with videos related to
Sort By:
Pageof 59
European Journal of Cancer (Oxford, England : 1990)|March 4, 2008
Where to position monoclonal antibodies in first-line treatment of advanced colorectal cancerChristopher Jackson, David CunninghamFuture Oncology (London, England)|December 5, 2014
Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancerFrancesco Sclafani, David CunninghamCurrent Treatment Options in Oncology|November 17, 2017
The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction CancerElizabeth Cartwright, David CunninghamEuropean Journal of Cancer (Oxford, England : 1990)|August 1, 2009
Current perspective: bevacizumab in colorectal cancer--a time for reappraisal?Alicia Okines, David CunninghamClinical Colorectal Cancer|April 12, 2008
A retrospective on the inhibition of epidermal growth factor receptor as a therapeutic strategy for patients with relapsed metastatic colorectal cancer: impact on treatment of today's patientsChristopher Jackson, David CunninghamJournal of Geriatric Oncology|February 4, 2014
Bevacizumab in elderly patients with metastatic colorectal cancerFrancesco Sclafani, David CunninghamCancer|September 5, 2002
Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for managementMehdi Shahidi, Andrew R Norman, David P Dearnaley, et al.BJU International|November 1, 2012
Diethylstilbestrol in castration-resistant prostate cancerAnna Wilkins, Mehdi Shahidi, Chris Parker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysisPadraig Warde, Lena Specht, Alan Horwich, et al.International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy +/- neoadjuvant androgen deprivationChris Parker, Padraig Warde, Andy Norman, et al.Pageof 59